List of Excipients in API dextromethorphan hydrobromide, bupropion hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dextromethorphan hydrobromide, bupropion hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | CARBOMER HOMOPOLYMER TYPE | 2034-11-05 |
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | CELLULOSE, MICROCRYSTALLINE | 2034-11-05 |
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | CROSPOVIDONE | 2034-11-05 |
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | CYSTEINE HYDROCHLORIDE | 2034-11-05 |
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | FERRIC OXIDE RED | 2034-11-05 |
Axsome Therapeutics Inc | AUVELITY | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 | FERRIC OXIDE YELLOW | 2034-11-05 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for dextromethorphan hydrobromide, bupropion hydrochloride
Excipient focus: CARBOMER HOMOPOLYMER TYPE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing CARBOMER HOMOPOLYMER TYPE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing CARBOMER HOMOPOLYMER TYPE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CYSTEINE HYDROCHLORIDE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing CYSTEINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing CYSTEINE HYDROCHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLATE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing GLYCERYL MONOCAPRYLATE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing GLYCERYL MONOCAPRYLATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dextromethorphan hydrobromide, bupropion hydrochloride drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Axsome Therapeutics Inc | dextromethorphan hydrobromide, bupropion hydrochloride | 81968-045 |
>Company | >Ingredient | >NDC |
dextromethorphan hydrobromide, bupropion hydrochloride drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.